| 12370233 |
Depot systems comprising glatiramer acetate |
Ehud Marom, Uri Danon, Shai Rubnov |
2025-07-29 |
| 12343371 |
Method for suppressing or alleviating primary or secondary progressive multiple sclerosis (PPMS or SPMS) using a sustained release depot formulation comprising glatiramer acetate |
Uri Danon, Laura Popper, Ehud Marom |
2025-07-01 |
| 12161688 |
Treatment of inflammatory bowel disease with long acting glatiramer and adipose-derived stem cells |
Ehud Marom, Frida Grynspan |
2024-12-10 |
| 12097292 |
Process for preparing microparticles containing glatiramer acetate |
Shai Rubnov, Ehud Marom |
2024-09-24 |
| 11865213 |
Semaglutide depot systems and use thereof |
Galina ZATS, Shai Rubnov, Ehud Marom |
2024-01-09 |
| 11471421 |
Process for preparing microparticles containing glatiramer acetate |
Shai Rubnov, Ehud Marom |
2022-10-18 |
| 11413311 |
Treatment of multiple sclerosis with long acting glatiramer and adipose-derived stem cells |
Ehud Marom, Frida Grynspan |
2022-08-16 |
| 11167003 |
Methods for suppressing or alleviating primary or secondary progressive multiple sclerosis (PPMS or SPMS) using sustained release glatiramer depot systems |
Uri Danon, Laura Popper, Ehud Marom |
2021-11-09 |
| 10493122 |
Sublingual delivery of glatiramer acetate |
Yoram Sela, Ehud Marom |
2019-12-03 |